Form 4: Director Casey Tansey Increases Stake in Inspire Medical
Statement of Changes in Beneficial Ownership
Director Casey M. Tansey acquired 308 shares of Inspire Medical Systems, Inc. common stock in lieu of cash director fees.
Summary
- Director Casey M. Tansey acquired 308 shares of common stock on April 15, 2026.
- The shares were issued at a price of $52.07 per share.
- The acquisition was made in lieu of cash compensation pursuant to the company's Non-Employee Director Compensation Policy.
- Following this transaction, the director holds 22,724 shares directly, with an additional 1,000 shares held indirectly through family trusts.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation that does not signal a change in company strategy or financial health.
Positives
- Demonstrates alignment of interest between the director and shareholders through equity ownership.
- Reflects confidence in the company's long-term value by opting for stock over cash compensation.
Negatives
- None identified in this filing.
Risks
- None identified in this filing.
Future Outlook
Not applicable as this is a routine disclosure of director compensation.
Industry Context
StockSavvy.ai notes that director equity-based compensation is a standard corporate governance practice designed to align board incentives with shareholder interests, particularly in the medical device sector.
Comparison to Industry Standards
- The practice of issuing stock in lieu of cash fees is consistent with standard compensation policies for non-employee directors in the healthcare technology industry.
- The transaction size is immaterial relative to the total market capitalization of Inspire Medical Systems.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Director Compensation | Issuance of common stock in lieu of cash fees per the Non-Employee Director Compensation Policy. | 04/15/2026 | Neutral; standard practice to align director interests with shareholders. |
Related Party Transactions
- The reporting person holds 500 shares in The Kimberly Tansey Irrevocable Trust and 500 shares in The Kylie Tansey Irrevocable Trust.
Stakeholder Impact
- Minimal impact on shareholders as the transaction is a standard compensation adjustment.
Key Dates
| Date | Description |
|---|---|
| 04/15/2026 | Date of the reported stock acquisition transaction. |
| 04/16/2026 | Date the Form 4 was filed with the SEC. |
Keywords
Inspire Medical Systems, INSP, Insider Trading, Director Compensation, Equity Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.